Dr. Kathryn Alsop
Honorary
The Sir Peter MacCallum Department of Oncology
22 Scholarly works
0 Projects
HIGHLIGHTS
2021
Journal article
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling
DOI: 10.1038/s41467-021-21576-82021
Book Chapter
The development of drug resistance through reversion mutation in BRCA genes in ovarian cancer
DOI: 10.1016/b978-0-12-819840-7.00013-32021
Conference Proceedings
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
DOI: 10.1038/s41379-020-0618-92020
Journal article
Prognostic gene expression signature for high-grade serous ovarian cancer
DOI: 10.1016/j.annonc.2020.05.0192020
Journal article
Sex differences in oncogenic mutational processes
DOI: 10.1038/s41467-020-17359-22020
Conference Proceedings
Drug resistance in end-stage high-grade serous ovarian cancer.
DOI: 10.1158/1557-3265.ovca19-ia042020
Conference Proceedings
Molecular analysis of exceptional response in high-grade serous ovarian cancer.
DOI: 10.1158/1557-3265.ovca19-ia05
RECENT SCHOLARLY WORKS
2020
Conference Proceedings
Spatial characterization of drug resistance in ovarian cancer.
DOI: 10.1158/1557-3265.ovca19-a652020
Journal article
Therapeutic options for mucinous ovarian carcinoma
DOI: 10.1016/j.ygyno.2019.12.0152020
Journal article
Pan-cancer analysis of whole genomes
DOI: 10.1038/s41586-020-1969-62020
Journal article
The MOCOG study: Learning from extraordinary responders to improve treatment outcomes for women with ovarian cancer
DOI: 10.1016/j.pathol.2020.01.1262019
Conference Proceedings
LONG-TERM SURVIVAL IN WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER: INTERPLAY BETWEEN RB1 AND BRCA1/2
DOI: 10.1136/ijgc-2019-ESGO.2082019
Journal article
The molecular origin and taxonomy of mucinous ovarian carcinoma
DOI: 10.1038/s41467-019-11862-x2019
Conference Proceedings
The genomic landscape of high-grade serous ovarian cancer in long-term survivors
DOI: 10.1158/1538-7445.AM2019-27222019
Journal article
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study
DOI: 10.1200/PO.19.00019